Philip A. Laskawy Sells 2,604 Shares of Henry Schein, Inc. (NASDAQ:HSIC) Stock

Henry Schein, Inc. (NASDAQ:HSIC) Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Henry Schein Stock Down 0.6 %

NASDAQ HSIC traded down $0.39 during trading on Thursday, reaching $70.45. 1,151,604 shares of the company’s stock traded hands, compared to its average volume of 1,506,691. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.49. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market cap of $8.75 billion, a price-to-earnings ratio of 28.99, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company’s 50 day simple moving average is $74.84 and its two-hundred day simple moving average is $72.62.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the firm earned $0.66 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently made changes to their positions in the stock. Nuance Investments LLC lifted its position in shares of Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after buying an additional 414,748 shares during the last quarter. Olstein Capital Management L.P. raised its stake in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Henry Schein during the third quarter valued at approximately $515,000. Private Management Group Inc. lifted its position in Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock valued at $24,256,000 after acquiring an additional 18,882 shares during the last quarter. Finally, Equitable Trust Co. purchased a new position in Henry Schein in the fourth quarter worth $417,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HSIC has been the topic of several analyst reports. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. UBS Group reduced their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Finally, Mizuho began coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.